【结 构 式】 |
【分子编号】59028 【品名】methyl (E,4S)-2-[(acetyloxy)methyl]-4-amino-2-pentenoate 【CA登记号】 |
【 分 子 式 】C9H15NO4 【 分 子 量 】201.22244 【元素组成】C 53.72% H 7.51% N 6.96% O 31.8% |
与该中间体有关的原料药合成路线共 2 条
合成路线1
该中间体在本合成路线中的序号:(V)The Baylis-Hillman reaction between N-Boc-alaninal (I) and methyl acrylate (II) in the presence of DABCO yields the allylic alcohol adduct (III). Subsequent Mitsunobu coupling with acetic acid leads to the rearranged allylic acetate (IV). Acidic Boc group cleavage in (IV) then gives the amino ester intermediate (V).
【1】 Zhu, S.; et al.; Synthesis and in vitro studies of novel pyrimidinyl peptidomimetics as potential antimalarial therapeutic agents. J Med Chem 2002, 45, 16, 3491. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 59029 | tert-butyl (1S)-1-methyl-2-oxoethylcarbamate | C8H15NO3 | 详情 | 详情 | |
(II) | 14156 | methyl acrylate | 96-33-3 | C4H6O2 | 详情 | 详情 |
(III) | 59026 | methyl 2-{(2S)-2-[(tert-butoxycarbonyl)amino]-1-hydroxypropyl}acrylate | C12H21NO5 | 详情 | 详情 | |
(IV) | 59027 | methyl (E,4S)-2-[(acetyloxy)methyl]-4-[(tert-butoxycarbonyl)amino]-2-pentenoate | C14H23NO6 | 详情 | 详情 | |
(V) | 59028 | methyl (E,4S)-2-[(acetyloxy)methyl]-4-amino-2-pentenoate | C9H15NO4 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(V)The pyrimidinone acetaldehyde (VI) is oxidized to the corresponding acid (VII) by means of sodium chlorite. Then, coupling of acid (VII) with amino ester (V) using DCC and HOBt provides the target amide.
【1】 Zhu, S.; et al.; Synthesis and in vitro studies of novel pyrimidinyl peptidomimetics as potential antimalarial therapeutic agents. J Med Chem 2002, 45, 16, 3491. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(V) | 59028 | methyl (E,4S)-2-[(acetyloxy)methyl]-4-amino-2-pentenoate | C9H15NO4 | 详情 | 详情 | |
(VI) | 51965 | benzyl 6-oxo-1-(2-oxoethyl)-2-phenyl-1,6-dihydro-5-pyrimidinylcarbamate | C20H17N3O4 | 详情 | 详情 | |
(VII) | 47808 | 2-[5-[[(benzyloxy)carbonyl]amino]-6-oxo-2-phenyl-1(6H)-pyrimidinyl]acetic acid | C20H17N3O5 | 详情 | 详情 |
Extended Information